WHO EpiData. A monthly summary of the epidemiological data on selected vaccine preventable diseases in the European Region

Similar documents
WHO EpiData. A monthly summary of the epidemiological data on selected Vaccine preventable diseases in the European Region

WHO EpiData. A monthly summary of the epidemiological data on selected Vaccine preventable diseases in the European Region

WHO EpiData. A monthly summary of the epidemiological data on selected Vaccine preventable diseases in the WHO European Region

WHO EpiData. A monthly summary of the epidemiological data on selected Vaccine preventable diseases in the European Region

WHO EpiData. A monthly summary of the epidemiological data on selected Vaccine preventable diseases in the European Region

WHO EpiData. A monthly summary of the epidemiological data on selected Vaccine preventable diseases in the WHO European Region

AD HOC DRAFTING GROUP ON TRANSNATIONAL ORGANISED CRIME (PC-GR-COT) STATUS OF RATIFICATIONS BY COUNCIL OF EUROPE MEMBER STATES

Weekly price report on Pig carcass (Class S, E and R) and Piglet prices in the EU. Carcass Class S % + 0.3% % 98.

United Nations Environment Programme

Economic and Social Council

United Nations Environment Programme

Publication Date: 15 Jan 2015 Effective Date: 12 Jan 2015 Addendum 6 to the CRI Technical Report (Version: 2014, Update 1)

USDA Dairy Import License Circular for 2018

Drawing the European map

04 June Dim A W V Total. Total Laser Met

USDA Dairy Import License Circular for 2018 Commodity/

Canadian Imports of Honey

Программа Организации Объединенных Наций по окружающей среде

EUROCONTROL. Short-Term Forecast. May Flight Movements EUROCONTROL

Supplementary Appendix for. Version: February 3, 2014

DISTILLED SPIRITS - IMPORTS BY VALUE DECEMBER 2017

Bilateral Labour Agreements, 2004

DISTILLED SPIRITS - IMPORTS BY VOLUME DECEMBER 2017

Governments that have requested pre-export notifications pursuant to article 12, paragraph 10 (a), of the 1988 Convention

Aerospace part number guide

PRECURSORS. Pseudoephedrine preparations 3,4-MDP-2-P a P-2-P b. Ephedrine

Most Recent Periodic Report Initial State Report. Next Periodic Accession/Ratification. Report Publication Publication. Report Due

International and regional network status

Country of Citizenship, College-Wide - All Students, Fall 2014

About the Authors Geography and Tourism: The Attraction of Place p. 1 The Elements of Geography p. 2 Themes of Geography p. 4 Location: The Where of

EuroGeoSurveys An Introduction

40 Years Listening to the Beat of the Earth

The EuCheMS Division Chemistry and the Environment EuCheMS/DCE

2008 Men's 20 European Championship / Qualification

A Markov system analysis application on labour market dynamics: The case of Greece

USDA Dairy Import License Circular for 2018

Bathing water results 2011 Slovakia

EuroGeoSurveys & ASGMI The Geological Surveys of Europe and IberoAmerica

Government Size and Economic Growth: A new Framework and Some Evidence from Cross-Section and Time-Series Data

How Well Are Recessions and Recoveries Forecast? Prakash Loungani, Herman Stekler and Natalia Tamirisa

Situation on the death penalty in the world. UNGA Vote 2012 Resolutio n 67/176. UNGA Vote 2010 Resolutio n 65/206. UNGA Vote 2008 Resolutio n 63/168

Bathing water results 2011 Latvia

An Online Open Access Journal ISSN Volume VII, Number 1, Chief Editor Tirtha Prasad mukhopadhyay

To facilitate data entry, three options are provided: - Data import using ASCII data transfers. - Data entry through time series

Vocabulary 2a Favourite characters aunt (n),, best (adj)

Composition of capital NO051

Composition of capital CY007 CY007 POWSZECHNACY007 BANK OF CYPRUS PUBLIC CO LTD

Composition of capital DE025

Composition of capital ES060 ES060 POWSZECHNAES060 BANCO BILBAO VIZCAYA ARGENTARIA S.A. (BBVA)

Composition of capital LU045 LU045 POWSZECHNALU045 BANQUE ET CAISSE D'EPARGNE DE L'ETAT

Composition of capital CY006 CY006 POWSZECHNACY006 CYPRUS POPULAR BANK PUBLIC CO LTD

Composition of capital DE028 DE028 POWSZECHNADE028 DekaBank Deutsche Girozentrale, Frankfurt

Composition of capital FR015

Composition of capital FR013

Composition of capital DE017 DE017 POWSZECHNADE017 DEUTSCHE BANK AG

Composition of capital ES059

F M U Total. Total registrants at 31/12/2014. Profession AS 2, ,574 BS 15,044 7, ,498 CH 9,471 3, ,932

The Chemical Weapons Convention, Biological and Toxin Weapons Convention, Geneva Protocol

Part 2. Cost-effective Control of Acidification and Ground-level Ozone

A COMPREHENSIVE WORLDWIDE WEB-BASED WEATHER RADAR DATABASE

Salmonella monitoring data and foodborne outbreaks for 2015 in the European Union

Almería 23 rd -25 th October th Joint Workshop of the European Union Reference Laboratories for Residues of Pesticides

PLUTO The Transport Response to the National Planning Framework. Dr. Aoife O Grady Department of Transport, Tourism and Sport

Appendices. Please note that Internet resources are of a time-sensitive nature and URL addresses may often change or be deleted.

natural gas World Oil and Gas Review

PROPOSED BUDGET FOR THE PROGRAMME OF WORK OF THE CONVENTION ON BIOLOGICAL DIVERSITY FOR THE BIENNIUM Corrigendum

COUNCIL. Hundred and Fifty-fifth Session. Rome, 5-9 December Status of Current Assessments and Arrears as at 29 November 2016.

Weighted Voting Games

Trends in Human Development Index of European Union

ESURFMAR Report to DBCP

APPENDIX IV Data Tables

NASDAQ OMX Copenhagen A/S. 3 October Jyske Bank meets 9% Core Tier 1 ratio in EU capital exercise

2010 Oracle Corporation 1

EUMETSAT. A global operational satellite agency at the heart of Europe. Presentation for the Spanish Industry Day Madrid, 15 March 2012

MB of. Cable. Wholesale. FWBA (fixed OAOs. connections of which Full unbundled. OAO owning. Internet. unbundled broadband

November 2014 CL 150/LIM 2 COUNCIL. Hundred and Fiftieth Session. Rome, 1-5 December 2014

ICC Rev August 2010 Original: English. Agreement. International Coffee Council 105 th Session September 2010 London, England

The trade dispute between the US and China Who wins? Who loses?

Bahrain, Israel, Jordan, Kuwait, Saudi Arabia, United Arab Emirates, Azerbaijan, Iraq, Qatar and Sudan.

This document is a preview generated by EVS

Measuring Instruments Directive (MID) MID/EN14154 Short Overview

JRC MARS Bulletin Crop monitoring in Europe. January 2017 Minor frost damages so far. Improved hardening of winter cereals in central Europe

Hundred and Fifty-sixth Session. Rome, 3-7 November Status of Current Assessments and Arrears as at 30 June 2014

E-SURFMAR Report. Jean ROLLAND Gilbert EMZIVAT Pierre BLOUCH Jon TURTON

Appendix B: Detailed tables showing overall figures by country and measure


PROPOSED BUDGET FOR THE PROGRAMME OF WORK OF THE CARTAGENA PROTOCOL ON BIOSAFETY FOR THE BIENNIUM Corrigendum

E-SURFMAR Report. Jean ROLLAND Michel TREMANT Pierre BLOUCH Jon TURTON

TIMSS 2011 The TIMSS 2011 Instruction to Engage Students in Learning Scale, Fourth Grade

EUROCONTROL Service Unit Forecast: December '09 Revision

DISTILLED SPIRITS - EXPORTS BY VALUE DECEMBER 2017

The School Geography Curriculum in European Geography Education. Similarities and differences in the United Europe.

Crop monitoring in Europe

PIRLS 2016 INTERNATIONAL RESULTS IN READING

APPLYING BORDA COUNT METHOD FOR DETERMINING THE BEST WEEE MANAGEMENT IN EUROPE. Maria-Loredana POPESCU 1

TIMSS 2011 The TIMSS 2011 Teacher Career Satisfaction Scale, Fourth Grade

SuperPack -Light. Data Sources. SuperPack-Light is for sophisticated weather data users who require large volumes of high quality world

This document is a preview generated by EVS

Big Data at BBVA Research using BigQuery

!! You!Say!You!Want!a!(Rose)!Revolution?!! The!Effects!of!Georgia s!2004!market!reforms!!!! Kevin!Grier! Texas!Tech!University!! Robert!Lawson*!

Transcription:

A monthly summary of the epidemiological data on selected vaccine preventable diseases in the European Region Table 1: Reported measles cases for the 12-month period February 2016 January 2017 (data as of 13 March 2017) Incidence Rate Feb 16 - Jan 17 measles cases Month and year of rash onset Feb-16 Mar-16 Apr-16 May-16 Jun-16 Jul-16 Aug-16 Sep-16 Oct-16 Nov-16 Dec-16 Jan-17 Month & year of last report Albania 2 903 700 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 Jan-17 Andorra 69 165 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 Jan-17 Armenia 3 026 048 0.7 2 0 0 - - 0 2 0 0 0 0 0 0 Jan-17 Austria 8 569 633 6.4 55 0 0 2 1 2 9 1 5 3 1 4 27 Jan-17 Azerbaijan 9 868 447 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 Jan-17 Belarus 9 481 521 3.1 29 1 0 0 0 0 15 6 1 5 1 0 0 Jan-17 Belgium 11 371 928 9.6 109 17 38 23 17 9 1 0 2 2 0 0 0 Jan-17 Bosnia and Herzegovina 3 802 134 7.1 27 27 - - - - - - - - - - - Feb-16 Bulgaria 7 097 796 0.1 1 1 0 0 0 0 0 0 0 0 0 0 0 Jan-17 Croatia 4 225 001 0.9 4 0 0 2 0 0 1 0 1 0 0 0 - Dec-16 Cyprus 1 176 598 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 Jan-17 Czech Republic 10 548 058 0.7 7 1 0 2 2 0 0 1 0 0 1 0 0 Jan-17 Denmark 5 690 750 0.5 3 0 0 1 0 0 0 1 0 0 0 1 0 Jan-17 Estonia 1 309 104 0.8 1 0 1 0 0 0 0 0 0 0 0 0 0 Jan-17 Finland 5 523 904 0.9 5 1 0 1 0 0 0 0 0 0 0 3 0 Jan-17 France 64 668 129 1.4 93 14 12 3 0 7 6 4 7 2 2 4 32 Jan-17 Georgia 3 979 781 3.3 13 0 0 2 0 4 3 1 1 0 2 0 0 Jan-17 Germany 80 682 351 4.6 369 7 15 33 60 51 44 27 24 16 30 10 52 Jan-17 Greece 10 919 459 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 Jan-17 Hungary 9 821 318 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 Jan-17 Iceland 331 778 3.0 1 0 0 0 0 0 0 1 0 0 0 0 0 Jan-17 Ireland 4 713 993 9.5 45 1 0 2 24 8 4 4 0 0 1 0 1 Jan-17 Israel 8 192 463 1.1 9 2-0 0 1 0 1 5-0 0 - Dec-16 Italy 59 801 004 17.1 1020 84 73 76 84 84 45 34 55 75 84 88 238 Jan-17 Kazakhstan 17 855 384 5.6 100 14 43 13 19 0 11-0 0 0 0 0 Jan-17 Kyrgyzstan 6 033 769 0.0 0 0 0 0 0 0 0 0 0 0 0-0 Jan-17 Latvia 1 955 742 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 Jan-17 Lithuania 2 850 030 7.7 22 0 0 10 10 2 0 0 0 0 0 0 0 Jan-17 Luxembourg 576 243 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 Jan-17 Malta 419 615 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 Jan-17 Monaco 37 862 - - - - - - - - - - - - - - No Report Montenegro 626 101 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 Jan-17 Netherlands 16 979 729 0.4 6 0 0 0 0 0 0 2 0 0 0 4 0 Jan-17 Norway 5 271 958 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 Jan-17 Poland 38 593 161 3.6 140 0 2 1 2 5 18 42 33 21 7 6 3 Jan-17 Portugal 10 304 434 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 Jan-17 Republic of Moldova 4 062 862 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 Jan-17 Romania 19 372 734 103.0 1995 41 62 67 78 102 113 182 219 417 129 474 111 Jan-17 Russian Federation 143 439 832 0.0 0 - - 0 - - - - - - - - - Apr-16 San Marino 31 950 - - - - - - - - - - - - - - No Report Serbia 8 812 705 1.6 14 0 1 0 0 0 0 0 0 0 5 8 0 Jan-17 Slovakia 5 429 418 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 Jan-17 Slovenia 2 069 362 1.4 3 0 0 0 1 0 0 0 0 0 0 0 2 Jan-17 Spain 46 064 604 0.8 39 0 9 9 0 2 3 2 3 2 6 2 1 Jan-17 Sweden 9 851 852 0.5 5 0 0 1 0 0 0 2 0 0 0 0 2 Jan-17 Switzerland 8 379 477 9.2 77 0 7 9 18 4 0 3 5 0 4 14 13 Jan-17 Tajikistan 8 669 464 11.1 96 0 0 0 7 9 0 0 0 1 24 11 44 Jan-17 Republic of Macedonia 2 081 012 0.0 0 0 0 0-0 0-0 0 0 0 0 Jan-17 Turkey 79 622 062 0.1 9 1 0 0 3 3 2 - - 0 - - - Oct-16 Turkmenistan 5 438 670 - - - - - - - - - - - - - - No Report Ukraine 44 624 373 2.5 111-0 3 2 0 0 5-8 44 24 25 Jan-17 United Kingdom 65 111 143 8.8 575 22 44 56 48 76 132 108 29 37 14 1 8 Jan-17 Uzbekistan 30 300 446 0.0 1 1 0 0 0 0-0 - 0-0 0 Jan-17 /Averages 912 640 057 5.46 4986 235 307 316 376 369 409 427 390 589 355 654 559 1 Source: "World Population Prospects: The 2015 Revision", New York, United Nations. 2 Incidence not meeting the target (<1) is highlighted in red. Member States submitting aggregate data: Bosnia and Herzegovina, Kazakhstan, Republic of Moldova, San Marino, Serbia, the former Yugoslav, Turkmenistan, Ukraine. For tables 1-4, the reporting of these data by year and month are based on cases with disease onset date during the 12-month period and corresponding month. Where disease onset date was unavailable, cases with the date of notification reported during these respective time periods were included. These monthly reported numbers may differ from reports produced by national or partner agencies if other dates (e.g. date of case reporting) are used.

Table 2: Reported rubella cases for the 12-month period February 2016 January 2017 (data as of 13 March 2017) Incidence Rate Feb 16 - Jan 17 rubella cases Month and year of rash onset Feb-16 Mar-16 Apr-16 May-16 Jun-16 Jul-16 Aug-16 Sep-16 Oct-16 Nov-16 Dec-16 Jan-17 Month & year of last report Albania 2 903 700 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 Jan-17 Andorra 69 165 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 Jan-17 Armenia 3 026 048 0.0 0 0 0 - - 0 0 0 0 0 0 0 0 Jan-17 Austria 8 569 633 0.4 3 1 1 0 0 0 0 1 0 0 0 0 0 Jan-17 Azerbaijan 9 868 447 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 Jan-17 Belarus 9 481 521 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 Jan-17 Belgium 3 11 371 928 - - 0 0 0 0 0 0 - - - - - - See footnote Bosnia and Herzegovina 3 802 134 0.0 0 0 - - - - - - - - - - - Feb-16 Bulgaria 7 097 796 0.4 3 0 0 0 0 0 1 0 0 0 1 1 0 Jan-17 Croatia 4 225 001 0.5 2 0 0 0 2 0 0 0 0 0 0 0 - Dec-16 Cyprus 1 176 598 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 Jan-17 Czech Republic 10 548 058 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 Jan-17 Denmark 3 5 690 750 - - 0 0 0 0 0 0 - - - - - 0 See footnote Estonia 1 309 104 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 Jan-17 Finland 5 523 904 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 Jan-17 France 3 64 668 129 - - 0 0 0 0 0 0 - - - - - - See footnote Georgia 3 979 781 2.8 11 0 0 1 3 3 1 0 0 1 0 1 1 Jan-17 Germany 80 682 351 1.1 92 6 4 18 13 10 15 3 4 5 7 4 3 Jan-17 Greece 10 919 459 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 Jan-17 Hungary 9 821 318 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 Jan-17 Iceland 331 778 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 Jan-17 Ireland 4 713 993 0.8 4 0 1 1 0 0 1 0 0 0 0 1 0 Jan-17 Israel 8 192 463 0.1 1 0-1 0 0 0 0 0-0 0 - Dec-16 Italy 59 801 004 0.5 28 2 3 1 7 5 1 1 0 2 4 2 0 Jan-17 Kazakhstan 17 855 384 0.2 4 1 0 1 0 0 0-1 0 1 0 0 Jan-17 Kyrgyzstan 6 033 769 0.3 2 1 0 0 0 1 0 0 0 0 0-0 Jan-17 Latvia 1 955 742 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 Jan-17 Lithuania 2 850 030 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 Jan-17 Luxembourg 576 243 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 Jan-17 Malta 419 615 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 Jan-17 Monaco 37 862 - - - - - - - - - - - - - - No Report Montenegro 626 101 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 Jan-17 Netherlands 16 979 729 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 Jan-17 Norway 5 271 958 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 Jan-17 Poland 38 593 161 27.4 1057 138 111 151 110 116 54 53 48 81 64 76 55 Jan-17 Portugal 10 304 434 0.6 6 1 1 0 1 2 0 0 0 0 1 0 0 Jan-17 Republic of Moldova 4 062 862 0.0 0 - - 0 0 - - 0 0 0 0 0 0 Jan-17 Romania 19 372 734 0.6 11 0 1 1 2 1 0 3 0 1 2 0 0 Jan-17 Russian Federation 143 439 832 - - - - - - - - - - - - - - No Report San Marino 31 950 - - - - - - - - - - - - - - No Report Serbia 8 812 705 - - - - - - - - - - - - - - No Report Slovakia 5 429 418 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 Jan-17 Slovenia 2 069 362 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 Jan-17 Spain 46 064 604 0.0 2 0 1 1 0 0 0 0 0 0 0 0 0 Jan-17 Sweden 9 851 852 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 Jan-17 Switzerland 8 379 477 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 Jan-17 Tajikistan 8 669 464 0.2 2 1 0 0 0 0 0 0 0 0 0 0 1 Jan-17 2 081 012 0.0 0 0 0 0-0 0 0 0 0 0 0 0 Jan-17 Turkey 79 622 062 - - - - - - - - - - - - - - No Report Turkmenistan 5 438 670 - - - - - - - - - - - - - - No Report Ukraine 44 624 373 - - - - - - - - - - - - - - No Report United Kingdom 65 111 143 0.0 2 0 1 0 0 0 0 0 0 0 1 0 0 Jan-17 Uzbekistan 30 300 446 0.0 0 0 0 0 0 0-0 - 0-0 0 Jan-17 /Averages 912 640 057 1.35 1230 151 124 176 138 138 73 61 53 90 81 85 60 1 Source: "World Population Prospects: The 2015 Revision", New York, United Nations. 2 Incidence not meeting the target (<1) is highlighted in red. 3 Belgium, Denmark, and France do not have comprehensive rubella surveillance systems. Member States submitting aggregate data: Bosnia and Herzegovina, Kazakhstan, Republic of Moldova, San Marino, Serbia, the former Yugoslav, Turkmenistan, Ukraine.

Table 3: Measles classification, reporting and surveillance performance, January 2017 (data as of 13 March 2017) Incidence Rate Jan 2017 measles cases 3 Lab confirmed Classification Epi-Link Clinically compatible 4 Albania 2 903 700 0 0 0 0 0 0 0 100% 0% Jan-17-0 - - Andorra 69 165 0 0 0 0 0 0 0 100% 100% Jan-17-0 - - Armenia 3 026 048 0 0 0 0 0 0 0 100% 100% Jan-17-0.00 - - Austria 8 569 633 2.7 27 25 2 0 2 4 100% 100% Jan-17 96% 0.02 93% 7% Azerbaijan 9 868 447 0 0 0 0 0 3 0 100% 100% Jan-17 100% 0.03 33% 33% Belarus 9 481 521 0 0 0 0 0 18 0 100% 100% Jan-17 100% 0.19 0 0 Belgium 11 371 928 0 0 0 0 0 0 0 100% 100% Jan-17-0.00 - - Bosnia and Herzegovina 3 802 134 - - - - - - - - - - - - - - Bulgaria 7 097 796 0 0 0 0 0 0 0 100% 100% Jan-17-0 - - Croatia 4 225 001 - - - - - - - - - - - - - - Cyprus 1 176 598 0 0 0 0 0 0 0 100% 100% Jan-17-0 - - Czech Republic 10 548 058 0 0 0 0 0 0 0 100% 100% Jan-17-0 - - Denmark 5 690 750 0 0 0 0 0 0 0 100% 100% Jan-17-0 - - Estonia 1 309 104 0 0 0 0 0 7 0 100% 100% Jan-17 100% 0.53 0 100% Finland 5 523 904 0 0 0 0 0 0 0 100% 100% Jan-17-0 - - France 64 668 129 0.3 32 15 7 10 0 11 100% 100% Jan-17 92% 0 88% 0 Georgia 3 979 781 0 0 0 0 0 2 0 100% 100% Jan-17 100% 0.05 100% 100% Germany 80 682 351 0.5 52 35 13 4 0 11 100% 100% Jan-17 87% 0 85% 0 Greece 10 919 459 0 0 0 0 0 0 0 100% 100% Jan-17-0 - - Hungary 9 821 318 0 0 0 0 0 0 0 100% 100% Jan-17-0.00 - - Iceland 331 778 0 0 0 0 0 0 0 100% 100% Jan-17-0 - - Ireland 4 713 993 0.2 1 0 0 1 0 0 100% 100% Jan-17 100% 0 100% 100% Israel 8 192 463 - - - - - - - - - - - - - - Italy 59 801 004 3.9 238 173 36 29 3 5 100% 100% Jan-17 87% 0.01 92% 0 Kazakhstan 17 855 384 0 0 0 0 0 0 0 100% 100% Jan-17-0 - - Kyrgyzstan 6 033 769 0 0 0 0 0 12 0 100% 100% Jan-17 100% 0.1989 100% 0 Latvia 1 955 742 0 0 0 0 0 0 0 100% 100% Jan-17-0 - - Lithuania 2 850 030 0 0 0 0 0 0 0 100% 100% Jan-17-0 - - Luxembourg 576 243 0 0 0 0 0 0 0 100% 100% Jan-17-0 - - Malta 419 615 0 0 0 0 0 0 0 100% 100% Jan-17-0 - - Monaco 37 862 - - - - - - - - - No Report - - - - Montenegro 626 101 0 0 0 0 0 0 0 100% 100% Jan-17-0 - - Netherlands 16 979 729 0 0 0 0 0 0 0 100% 100% Jan-17-0 - - Norway 5 271 958 0 0 0 0 0 0 0 100% 100% Jan-17-0 - - Poland 38 593 161 0.1 3 2 0 1 0 0 100% 100% Jan-17 67% 0 100% 100% Portugal 10 304 434 0 0 0 0 0 0 0 100% 100% Jan-17-0.00 - - Republic of Moldova 4 062 862 0 0 0 0 0 0 0 100% 100% Jan-17-0 - - Romania 19 372 734 5.7 111 51 60 0 0 0 100% 100% Jan-17 100% 0 100% 100% Russian Federation 143 439 832 - - - - - - - - - - - - - - San Marino 31 950 - - - - - - - - - No Report - - - - Serbia 8 812 705 0 0 0 0 0 0 0 100% 100% Jan-17-0 - - Slovakia 5 429 418 0 0 0 0 0 0 0 100% 100% Jan-17-0.00 - - Slovenia 2 069 362 0.5 2 2 0 0 0 1 100% 100% Jan-17 100% 0 100% 100% Spain 46 064 604 0 1 1 0 0 0 1 100% 100% Jan-17 100% 0.00 100% 100% Sweden 9 851 852 0 2 2 0 0 0 2 100% 100% Jan-17 100% 0 100% 0 Switzerland 8 379 477 1.6 13 11 0 2 10 0 100% 100% Jan-17 100% 0.12 52% 100% Tajikistan 8 669 464 5.1 44 44 0 0 18 0 100% 100% Jan-17 100% 0.21 15% 100% 2 081 012 0 0 0 0 0 0 0 100% 100% Jan-17-0 - - Turkey 79 622 062 - - - - - - - - - - - - - - Turkmenistan 5 438 670 - - - - - - - - - No Report - - - - Ukraine 44 624 373 0.6 25 0 0 25 0 0 100% 100% Jan-17 0% 0 0 0 United Kingdom 65 111 143 0.0 8 8 0 0 0 6 100% 100% Jan-17 100% 0 75% 0 Uzbekistan 30 300 446 0 0 0 0 0 4 0 100% 100% Jan-17 100% 0.01 100% 0 /Averages 912 640 057 0.6 559 369 118 72 79 41 84.9% 83.0% 88.7% 0.01 76.3% 34.0% 1 Source: " World Population Prospects: The 2015 Revision", New York, United Nations. Discarded Measles Imported cases Completeness Reporting Timeliness Month & year of last report Laboratory investigation rate Surveillance Indicators Rate of discarded cases Origin of infection Timeliness of investigation 2 Incidence not meeting the target (<1) and countries not reporting monthly measles data are highlighted in red. The measles imported cases are excluded from measles cases (numerator). 3 All confirmed measles cases regardless of origin. 4 Unless specified as laboratory confirmed or epi-linked, cases are classified as clinically compatible. Member States submitting aggregate data: Bosnia and Herzegovina, Kazakhstan, Republic of Moldova, San Marino, Serbia, the former Yugoslav, Turkmenistan, Ukraine.

Table 4: Rubella classification, reporting and surveillance performance, January 2017 (data as of 13 March 2017) Incidence Rate Jan 2017 rubella cases 3 Lab confirmed Classification Epi-Link Clinically compatible 4 Discarded Rubella Imported cases Completeness Reporting Timeliness Month of last report Laboratory investigation rate Surveillance Indicators Rate of discarded cases Origin of infection Timeliness of investigation Albania 2 903 700 0 0 0 0 0 0 0 100% 0% Jan-17-0 - - Andorra 69 165 0 0 0 0 0 0 0 100% 100% Jan-17-0 - - Armenia 3 026 048 0 0 0 0 0 1 0 100% 100% Jan-17 100% 0.03 100% 100% Austria 8 569 633 0 0 0 0 0 0 0 100% 100% Jan-17-0 - - Azerbaijan 9 868 447 0 0 0 0 0 1 0 100% 100% Jan-17 100% 0.01 0% 100% Belarus 9 481 521 0 0 0 0 0 18 0 100% 100% Jan-17 0% 0.1898 0% 0% Belgium 5 11 371 928 - - - - - - - - - See footnote - - - - Bosnia and Herzegovina 3 802 134 - - - - - - - - - - - - - - Bulgaria 7 097 796 0 0 0 0 0 0 0 100% 100% Jan-17-0 - - Croatia 4 225 001 - - - - - - - - - - - - - - Cyprus 1 176 598 0 0 0 0 0 0 0 100% 100% Jan-17-0 - - Czech Republic 10 548 058 0 0 0 0 0 0 0 100% 100% Jan-17-0 - - Denmark 5 5 690 750 - - - - - - - - - See footnote - - - - Estonia 1 309 104 0 0 0 0 0 1 0 100% 100% Jan-17 100% 0.08 100% 100% Finland 5 523 904 0 0 0 0 0 0 0 100% 100% Jan-17-0 - - France 5 64 668 129 - - - - - - - - - See footnote - - - - Georgia 3 979 781 0.3 1 1 0 0 0 0 100% 100% Jan-17 100% 0.00 100% 100% Germany 80 682 351 0.0 3 1 0 2 0 0 100% 100% Jan-17 33% 0 33% 0% Greece 10 919 459 0 0 0 0 0 0 0 100% 100% Jan-17-0 - - Hungary 9 821 318 0 0 0 0 0 0 0 100% 100% Jan-17-0.00 - - Iceland 331 778 0 0 0 0 0 0 0 100% 100% Jan-17-0 - - Ireland 4 713 993 0 0 0 0 0 0 0 100% 100% Jan-17-0 - - Israel 8 192 463 - - - - - - - - - - - - - - Italy 59 801 004 0 0 0 0 0 0 0 100% 100% Jan-17-0.00 - - Kazakhstan 17 855 384 0 0 0 0 0 0 0 100% 100% Jan-17-0 - - Kyrgyzstan 6 033 769 0 0 0 0 0 0 0 100% 100% Jan-17-0 - - Latvia 1 955 742 0 0 0 0 0 0 0 100% 100% Jan-17-0 - - Lithuania 2 850 030 0 0 0 0 0 0 0 100% 100% Jan-17-0 - - Luxembourg 576 243 0 0 0 0 0 0 0 100% 100% Jan-17-0 - - Malta 419 615 0 0 0 0 0 0 0 100% 100% Jan-17-0 - - Monaco 37 862 - - - - - - - - - No Report - - - - Montenegro 626 101 0 0 0 0 0 0 0 100% 100% Jan-17-0 - - Netherlands 16 979 729 0 0 0 0 0 0 0 100% 100% Jan-17-0 - - Norway 5 271 958 0 0 0 0 0 0 0 100% 100% Jan-17-0 - - Poland 38 593 161 1.4 55 0 0 55 0 0 100% 100% Jan-17 0% 0 0% 0% Portugal 10 304 434 0 0 0 0 0 0 0 100% 100% Jan-17-0.00 - - Republic of Moldova 4 062 862 0 0 0 0 0 0 0 100% 100% Jan-17-0 - - Romania 19 372 734 0 0 0 0 0 0 0 100% 100% Jan-17-0 - - Russian Federation 143 439 832 - - - - - - - - - No Report - - - - San Marino 31 950 - - - - - - - - - No Report - - - - Serbia 8 812 705 - - - - - - - - - No Report - - - - Slovakia 5 429 418 0 0 0 0 0 0 0 100% 100% Jan-17-0 - - Slovenia 2 069 362 0 0 0 0 0 0 0 100% 100% Jan-17-0 - - Spain 46 064 604 0 0 0 0 0 0 0 100% 100% Jan-17-0.00 - - Sweden 9 851 852 0 0 0 0 0 0 0 100% 100% Jan-17-0.00 - - Switzerland 8 379 477 0 0 0 0 0 1 0 100% 100% Jan-17 100% 0.01 0% 0% Tajikistan 8 669 464 0.1 1 1 0 0 3 0 100% 100% Jan-17 100% 0.03 100% 100% 2 081 012 0 0 0 0 0 0 0 100% 100% Jan-17-0 - - Turkey 79 622 062 - - - - - - - - - No Report - - - - Turkmenistan 5 438 670 - - - - - - - - - No Report - - - - Ukraine 44 624 373 - - - - - - - - - No Report - - - - United Kingdom 65 111 143 0 0 0 0 0 0 0 100% 100% Jan-17-0 - - Uzbekistan 30 300 446 0 0 0 0 0 0 0 100% 100% Jan-17-0.00 - - /Averages 912 640 057 0.1 60 3 0 57 25 0 77.4% 75.5% 11.8% 0.00 9.4% 9.4% 1 Source: World Population Prospects: The 2015 Revision", New York, United Nations. 2 Incidence not meeting the target (<1) and countries not reporting monthly rubella data are highlighted in red. The rubella imported cases are excluded from rubella cases (numerator). 3 All confirmed rubella cases regardless of origin. 4 Unless specified as laboratory confirmed or epi-linked, cases are classified as clinically compatible. 5 Belgium, Denmark, and France do not have comprehensive rubella surveillance systems. Member States submitting aggregate data: Bosnia and Herzegovina, Kazakhstan, Republic of Moldova, San Marino, Serbia, the former Yugoslav, Turkmenistan, Ukraine.

Table 5: Measles and rubella laboratory test results, January - December 2016 (data as of 01 February 2017) Measles Rubella Reporting to CISID / MRLDMS % % sequencing Genotypes sequencing Positive Genotypes % Positive for reported % Timeliness last report Month of specimen reported to reported specimen for rubella reported to Completeness measles (%) within 60 s tested MeaNS 1 within 60 stested (%) RubeNS 2 days 1 days 2 Albania 17 1 (6.0) - - 2 0 (0.0) - - 100.0% 75.0% Dec-16 Andorra - No Lab Armenia 111 1 (1.0) - - 111 0 (0.0) - - 83.3% 16.7% Oct-16 Austria 1235 21 (2.0) B3, D8 94% 5274 3 (0.0) - - 100.0% 100.0% Dec-16 Azerbaijan 175 0 (0.0) - - 202 0 (0.0) - - 100.0% 66.7% Dec-16 Belarus 462 51 (11.0) D8, H1 67% 427 0 (0.0) - - 100.0% 83.3% Dec-16 Belgium 269 61 (23.0) B3, D8 79% 54 10 (19.0) - - 100.0% 58.3% Dec-16 Bosnia and Herzegovina 19 (0.0) - - 19 (0.0) - - 58.0% 0 Dec-16 Bulgaria 46 1 (2.0) H1 0% 45 0 (0.0) - - 100.0% 91.7% Dec-16 Croatia - - D8 100% - - - - - No Report Cyprus 163 0 (0.0) - - 168 0 (0.0) - - 100.0% 91.7% Dec-16 Czech Republic 30 11 (37.0) - - 1 0 (0.0) - - 100.0% 91.7% Dec-16 Denmark 405 10 (2.0) B3, D8 33% 56 0 (0.0) - - 100.0% 91.7% Dec-16 Estonia 77 2 (3.0) D8 100% 477 2 (0.0) - - 100.0% 91.7% Dec-16 Finland 244 15 (6.0) D8 33% 309 1 (0.0) - - 100.0% 33.3% Dec-16 France 395 76 (19.0) B3, D8 93% 185 28 (15.0) 1E 100% 100.0% 16.7% Dec-16 Georgia 49 1 (2.0) D8 0% 53 1 (2.0) - - 41.7% 16.7% May-16 Germany - - B3, D8, H1 54% - - - - - No Report Greece 13 1 (8.0) - - 230 54 (23.0) - - 100.0% 16.7% Dec-16 Hungary 105 0 (0.0) - - 127 0 (0.0) - - 100.0% 91.7% Dec-16 Iceland - - - - - - - - - No Report Ireland 1102 108 (10.0) B3, D8 97% 1672 2 (0.0) - - 100.0% 66.7% Dec-16 Israel 221 35 (16.0) D8 56% 621 1 (0.0) 2B 0% 100.0% 91.7% Dec-16 Italy 286 183 (64.0) B3, D8 38% 140 0 (0.0) 1G 0% 100.0% 66.7% Dec-16 Kazakhstan 193 65 (34.0) H1 50% 166 3 (2.0) - - 83.3% 75.0% Dec-16 Kyrgyzstan 0 0 - - 0 0 - - 0 0 Jun-16 Latvia 220 0 (0.0) - - 272 0 (0.0) - - 100.0% 83.3% Dec-16 Lithuania 182 27 (15.0) - - 163 0 (0.0) - - 100.0% 83.3% Dec-16 Luxembourg 95 0 (0.0) - - 4 0 (0.0) - - 100.0% 91.7% Dec-16 Malta 43 0 (0.0) - - 1598 0 (0.0) - - 100.0% 91.7% Dec-16 Monaco No Lab Montenegro No Lab Netherlands 9 0 (0.0) D8 100% 9 0 (0.0) - - 50.0% 0 Dec-16 Norway 0 0 - - 0 0 - - 58.0% 0 Feb-16 Poland 47 0 (0.0) D8 33% 47 0 (0.0) - - 58.0% 0 Dec-16 Portugal 21 0 (0.0) - - 21 0 (0.0) - - 75.0% 0 Dec-16 Republic of Moldova 62 0 (0.0) - - 62 0 (0.0) - - 100.0% 83.3% Dec-16 Romania 1827 1379 (75.0) B3 100% 453 14 (3.0) - - 100.0% 91.7% Dec-16 Russian Federation 3982 308 (8.0) D8, H1 84% 3954 80 (2.0) 2B 86% 100.0% 83.3% Dec-16 San Marino No Lab Serbia 3 0 (0.0) B3 0% 3 0 (0.0) - - 8.3% 8.3% Feb-16 Slovakia 5 0 (0.0) - - 5 0 (0.0) - - 100.0% 91.7% Dec-16 Slovenia 53 2 (4.0) B3 100% 6 0 (0.0) - - 100.0% 91.7% Dec-16 Spain - - B3, D8 76% - - - - - No Report Sweden 565 11 (2.0) B3, D8 100% 1742 8 (0.0) - - 100.0% 8.3% Dec-16 Switzerland 164 88 (54.0) D8 50% 8 8 (100.0) - - 100.0% 83.3% Dec-16 Tajikistan 0 0 - - 0 0 - - 58.0% 0 Dec-16 19 0 (0.0) - - 449 0 (0.0) - - 41.7% 0 May-16 Turkey 2364 73 (3.0) - - 2064 48 (2.0) 1H 0% 100.0% 91.7% Dec-16 Turkmenistan # - - - - - - - - - No Report Ukraine 604 30 (5.0) D8 25% 598 2 (0.0) - - 100.0% 83.3% Dec-16 United Kingdom 4633 999 (22.0) B3, D8, D4 98% 2147 6 (0.0) - - 100.0% 41.7% Dec-16 Uzbekistan 152 1 (1.0) - - 152 0 (0.0) - - 100.0% 91.7% Dec-16 / Average 20667 3561 (17%) 77% 24096 271 (1%) 64% 65.3% 47.8% Data source: Aggregated monthly data provided by regional measles and rubella laboratory network (MR Labnet) to WHO/Europe. Some countries are only reporting to specimen-based MR lab data management system (MR LDMS). #Turkmenistan lab data not displayed as lab reporting does not match the required format and frequency. 1 MeaNS: http://www.who-measles.org/. Timeliness of sequence reporting relates to the time between specimen collection and reporting to MeaNS. 2 RubeNS: http://www.who-rubella.org/. Timeliness of sequence reporting relates to the time between specimen collection and reporting to RubeNS. *Specimen based data are not population based, and should not be interpreted as indicators for epidemiological surveillance. Laboratories may have received more than 1 clinical sample or may have conducted more than 1 test for a given case reported in Table 1.

Figure 1: Distribution of named strains of D8 Measles Genotype by week of 2016 (data as of 7 March 2017)* 45 40 35 D8 Not named D8 MVs/Victoria.AUS/6.11/ D8 MVs/Frankfurt Main.DEU/17.11/ D8 MVs/Cambridge.GBR/5.16/ D8 MVi/Villupuram.IND/03.07/ D8 MVi/Hulu Langat.MYS/26.11/ 30 25 20 15 10 5 0 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 2016 Figure 2: Distribution of named strains of B3 Measles Genotype by week of 2016 (data as of 7 March 2017)* 18 16 14 12 B3 Not named B3 MVs/Iasi.ROU/19.15/ B3 MVs/Dublin.IRL/8.16/ B3 MVs/Allada.BEN/3.10/ B3 MVi/Harare.ZWE/38.09/ 10 8 6 4 2 0 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 2016 *The data source of above graphs are MeaNS (http://www.who-measles.org) Contact us: Vaccine preventable Diseases and Immuniza on Programme, WHO Regional Office for Europe Tel.: +45 45 33 70 00 E mail: euvaccine@who.int and/or eucddata@who.int Web site: h p://www.euro.who.int/vaccine World Health Organiza on, 2017.

2024 © sciencedocbox.com Privacy Policy | Terms of Service | Feedback